InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by BURGESS DANIEL D, Director. Insider active across 1 company, notably Nabriva Therapeutics plc. In total, 5 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €4k. Activity tracked since 28 July 2021. The latest transaction was disclosed on 2 August 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
11,341 shares@ US$0.190148.3% of flowOrdinary SharesSEC:0001104659-22-086282:0
1,125 shares@ US$1.2050.0% of flowOrdinary SharesSEC:0001104659-21-100290:0
1,125 shares@ US$1.2025.9% of flowOrdinary SharesSEC:0001104659-21-100290
17,500 shares0Ordinary SharesSEC:0001104659-21-098429:0
17,500 shares0Ordinary SharesSEC:0001104659-21-098429
5 of 5 declarations
About BURGESS DANIEL D
Daniel D. Burgess is a Board Member at Nabriva Therapeutics plc. He contributes to the governance of the company by participating in strategic decision-making and ensuring operational compliance. His role is important for the success and growth of the company.
